Cover Image
Market Research Report

Blood Pressure Monitoring Market Report | United States | 2019-2025 | MedCore

Published by iData Research Inc. Product code 370981
Published Content info 503 Pages
Delivery time: 1-2 business days
Price
Back to Top
Blood Pressure Monitoring Market Report | United States | 2019-2025 | MedCore
Published: January 1, 2019 Content info: 503 Pages
Description

Abnormal blood pressure levels are characterized by levels that are too high or too low. Hypertension refers to instances where an individual's blood pressure is more elevated than "normal." Hypotension refers to instances where the individual's blood pressure is lower than "normal." Both conditions may result in further health complications. For most individuals, healthy blood pressure ranges from 110/70 mmHg to 130/90 mmHg.

The personal market is set to increase as more Americans adopt blood pressure monitoring practices. Both markets will continue to see an increase in digital sphygmomanometer sales, as aneroid kits are primarily purchased by medical schools, school boards, fitness professionals and some physician offices. Even then, the ease of use and attraction of digital devices is gaining popularity amongst the medical professional community.

Table of Contents
Product Code: iDATA_USPME19_MC_BPM

Table of Contents

TABLE OF CONTENTS I

LIST OF FIGURES XVIII

LIST OF CHARTS XX

EXECUTIVE SUMMARY 1

U.S. PATIENT MONITORING EQUIPMENT MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 9

MARKET DEVELOPMENTS 11

MARKETS INCLUDED 14

KEY REPORT UPDATES 19

VERSION HISTORY 19

RESEARCH METHODOLOGY 20

    • Step 1: Project Initiation & Team Selection 20
    • Step 2: Prepare Data Systems and Perform Secondary Research 23
    • Step 3: Preparation for Interviews & Questionnaire Design 25
    • Step 4: Performing Primary Research 26
    • Step 5: Research Analysis: Establishing Baseline Estimates 28
    • Step 6: Market Forecast and Analysis 29
    • Step 7: Identify Strategic Opportunities 31
    • Step 8: Final Review and Market Release 32
    • Step 9: Customer Feedback and Market Monitoring 33

BLOOD PRESSURE MONITORING MARKET 34

  • 2.1 INTRODUCTION 34
    • 2.1.1 Aneroid versus Digital Blood Pressure Monitoring 35
  • 2.2 MARKET OVERVIEW 36
  • 2.3 MARKET ANALYSIS AND FORECAST 40
    • 2.3.1 Total Personal Blood Pressure Monitoring Market 40
      • 2.3.1.1 Digital Personal Blood Pressure Monitoring Market 44
      • 2.3.1.2 Aneroid Personal Blood Pressure Monitoring Market 46
    • 2.3.2 Total Professional Blood Pressure Monitoring Market 48
      • 2.3.2.1 Digital Professional Blood Pressure Monitoring Market 52
      • 2.3.2.2 Aneroid Professional Blood Pressure Monitoring Market 55
  • 2.4 DRIVERS AND LIMITERS 57
    • 2.4.1 Market Drivers 57
    • 2.4.2 Market Limiters 58
  • 2.5 COMPETITIVE MARKET SHARE ANALYSIS 60

ABBREVIATIONS 65

APPENDIX: COMPANY PRESS RELEASES 68

  • 4.1 INTRODUCTION 68
  • 4.2 PRESS RELEASES 68
    • 4.2.1 Draeger Medical 69
      • 4.2.1.1 First half of 2018: Drager increases net sales 69
      • 4.2.1.2 New HealthTrust Agreement Covers Drager's Line of Anesthesia Solutions 70
      • 4.2.1.3 Drager and ICON Prepared to Support Hospitals with Ventilators During Times of Crisis 71
      • 4.2.1.4 Drager First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems 71
      • 4.2.1.5 Drager Infinity M300 Monitor Now Features FIPS Security 72
      • 4.2.1.6 Drager First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems 74
      • 4.2.1.7 Drager to Discuss Alarm Management and Strategies for Eliminating "Alarm Fatigue" at HIMSS16 75
    • 4.2.2 Edwards Lifesciences 77
      • 4.2.2.1 Edwards Lifesciences Reports Second Quarter Results 77
      • 4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S. 79
      • 4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results 80
      • 4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 83
      • 4.2.2.5 Edwards Acquires Harpoon Medical 85
      • 4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance 85
      • 4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results 86
      • 4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio 89
      • 4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator 91
      • 4.2.2.10 Edwards Lifesciences Reports Second Quarter Results 92
      • 4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors 92
      • 4.2.2.12 Edwards Lifesciences Reports First Quarter Results 93
      • 4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of Directors 95
      • 4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results 96
    • 4.2.3 Fukuda Denshi 100
      • 4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. A High Performance Color Portable Ultrasound Unit Designed for a Wide Array of Specialty Markets 100
      • 4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi USA Inc. and Amerinet Choice License and Supply Agreement 100
    • 4.2.4 GE Healthcare 102
      • 4.2.4.1 GE Healthcare Introduces Virtual Reality Training for Healthcare Technology Management Professionals 102
      • 4.2.4.2 GE Healthcare and FitTrace announce collaboration to offer body composition analysis software for sports and fitness markets 103
      • 4.2.4.3 GE Healthcare and Preventice Solutions Collaborate to Extend the Heart Station Beyond the Hospital 104
      • 4.2.4.4 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion 105
      • 4.2.4.5 GE Healthcare, Ferozsons L.L. and P&SHD collaborate to deliver comprehensive training program for Maternal, Newborn & Child Health (MNCH) 106
      • 4.2.4.6 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom's healthcare sector 107
      • 4.2.4.7 GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment 109
      • 4.2.4.8 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years 110
      • 4.2.4.9 GE Healthcare Receives Carequality Certification, Advancing Data Exchange with Cloud Technology 111
      • 4.2.4.10 Catherine Estrampes appointed President & CEO of GE Healthcare Europe 113
      • 4.2.4.11 GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes 114
      • 4.2.4.12 Emmanuel Ligner named President and CEO of GE Healthcare Life Sciences 115
      • 4.2.4.13 GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration 115
      • 4.2.4.14 Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 117
      • 4.2.4.15 Refurbished Parts for GE Diagnostic Imaging Equipment Now Available from GE Healthcare 118
      • 4.2.4.16 Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey 119
      • 4.2.4.17 GE to help transform over 200 hospitals in Egypt with 700 units of its advanced healthcare technologies 122
      • 4.2.4.18 GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare 123
      • 4.2.4.19 Boston Children's Hospital and GE Healthcare Working Together to Create Smart Imaging Technology to Better Detect Pediatric Brain Disorders 124
      • 4.2.4.20 GE Healthcare showcases industry-first technologies and digital solutions, focused on improving outcomes, at RSNA 2016 126
      • 4.2.4.21 GE Healthcare Taps Into $28 Billion Orphaned IP Market With Stake in Pilot Lite Ventures 127
      • 4.2.4.22 UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally 128
      • 4.2.4.23 Exploring digital solutions to combat heart disease 130
      • 4.2.4.24 The OR Goes Digital: New Apps Drive Operational and Economic Outcomes 130
      • 4.2.4.25 GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea 131
      • 4.2.4.26 See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians 132
      • 4.2.4.27 GE to invest €150 million in biopharmaceutical manufacturing campus in Cork, Ireland, and establish advanced manufacturing training centre at NIBRT 134
      • 4.2.4.28 Boosting Compact Ultrasound IQ: GE Healthcare's New Vivid™ iq Combines Power and Portability 135
      • 4.2.4.29 GE Healthcare launches next generation Biacore? molecular interaction analysis platform 136
      • 4.2.4.30 GE Healthcare and Uppsala BIO form a new partnership 137
      • 4.2.4.31 Charles Koontz Appointed President and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer 138
    • 4.2.5 Honeywell Life Sciences 139
      • 4.2.5.1 Honeywell Incorporates Integrated Video Capability Into Telehealth Platform Allowing Healthcare Professionals To Treat Patients In Their Homes 139
      • 4.2.5.2 Honeywell Unveils New Version of FDA-Cleared Telehealth Software 140
      • 4.2.5.3 Honeywell Presents Its Latest Connected Technologies That Help Reduce Clinical Errors At Saudi Health Exhibition 142
      • 4.2.5.4 Honeywell Hosts Annual Investor Conference; Reaffirms First Quarter And Full-Year 2016 Outlook; Targets 2017 Core Organic Sales Up 4-5% 143
    • 4.2.6 Masimo 144
      • 4.2.6.1 New Study Investigates Impact of General Ward Clinical Monitoring Using Masimo Root®, Radius-7®, and Patient SafetyNet™ on Clinical Workflow and Patient Care 144
      • 4.2.6.2 New Study Investigates the Utility of Masimo Pvi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery 146
      • 4.2.6.3 Masimo Announces Vital Signs Check Application for the Root® Patient Monitoring and Connectivity Platform 147
      • 4.2.6.4 New Study Investigates the Utility of Masimo Ori™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation 148
      • 4.2.6.5 United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™ 149
      • 4.2.6.6 Masimo and PositiveID Announce the U.S. Release of TIR-1™ 151
      • 4.2.6.7 New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers 152
      • 4.2.6.8 New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration 153
      • 4.2.6.9 Women's Tennis Association to Use Masimo MightySat™ Fingertip Pulse Oximeters to Advance Player Health and Performance 154
      • 4.2.6.10 New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in Reducing Unnecessary Blood Transfusions 155
      • 4.2.6.11 Masimo SET® Pulse Oximetry Helps Form Basis of Utah Senate Resolution on Postoperative Oxygen Saturation Home Monitoring for Patients Prescribed Opioids 156
      • 4.2.6.12 Masimo Reports First Quarter 2018 Financial Results 158
      • 4.2.6.13 New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices 162
      • 4.2.6.14 Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® with Integrated NomoLine™ Capnography 163
      • 4.2.6.15 Masimo Announces UniView™ 164
      • 4.2.6.16 New Study Investigates the Performance of Masimo SpHb® During Acute Bleeding and After Fluid Resuscitation 166
      • 4.2.6.17 Masimo Announces Replica™ 167
      • 4.2.6.18 Leading Nephrology Care Center in India Adopts Masimo Technologies Across Continuum of Care 167
      • 4.2.6.19 New Study Evaluates the Performance of Masimo SpHb® in Monitoring Pediatric Trauma Patients 168
      • 4.2.6.20 New Study Evaluates the Performance of Masimo Pvi® as a Predictor of Fluid Responsiveness in Mechanically Ventilated ICU Patients 169
      • 4.2.6.21 Masimo Announces CE Marking of Eve™ CCHD Newborn Screening Application for the Rad-97™ Pulse CO-Oximeter® 170
      • 4.2.6.22 Masimo Announces FDA Clearance of Next Generation SedLine® Brain Function Monitoring 171
      • 4.2.6.23 New Study Investigates the Clinical Utility of Ori™, Masimo Oxygen Reserve Index™, in Obese Patients 172
      • 4.2.6.24 Masimo Announces FDA Clearance for Home Use of Rad-97™ 173
      • 4.2.6.25 Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors 174
      • 4.2.6.26 Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas 175
      • 4.2.6.27 Masimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling Lines 177
      • 4.2.6.28 Masimo Supports World Pneumonia Day Efforts 178
      • 4.2.6.29 Masimo Announces Distribution of Rad-57® Pulse CO-Oximeters® by The Jeffrey Lee Williams Foundation to First Responders 179
      • 4.2.6.30 Masimo Announces U.S. Release of Trace™ Data Visualization and Reporting Tool 180
      • 4.2.6.31 Masimo Announces Full Market Release of rainbow Acoustic Monitoring Sensor RAS-45 181
      • 4.2.6.32 Masimo Announces FDA Clearance and Full Market Release of Rad-97™ Pulse CO-Oximeter® 182
      • 4.2.6.33 Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child 184
      • 4.2.6.34 Study Evaluates Performance of Masimo iSpO2® Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease 186
      • 4.2.6.35 Study Evaluates Utility of Masimo SpHb® During High-Blood-Loss Oncosurgery 187
      • 4.2.6.36 Study Investigates Performance of Masimo Pvi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery 188
      • 4.2.6.37 Dubai Health Authority Implements Masimo Patient SafetyNet™ 189
      • 4.2.6.38 Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels 190
      • 4.2.6.39 Study Compares Performance of Masimo Acoustic Respiration Rate (Rra®) and Nellcor Plethysmographic Respiration Rate in Volunteers 191
      • 4.2.6.40 Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength Index of Pleth Variability 193
      • 4.2.6.41 Masimo Announces CE Marking of rainbow® Super Sensor 193
      • 4.2.6.42 New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (Psi) to Original Psi During Anesthesia 195
      • 4.2.6.43 New Study Investigates the Clinical Utility of Ori™, Masimo Oxygen Reserve Index™ 196
      • 4.2.6.44 Masimo Announces Limited Market Release of Rad-67™ rainbow® Pulse CO-Oximeter® with Next Generation SpHb® 197
      • 4.2.6.45 Masimo and Mdoloris Announce Masimo Open Connect™ (MOC) Partnership for the Root® Patient Monitoring and Connectivity Hub 198
      • 4.2.6.46 Masimo Announces FDA 510(k) Clearance of O3™ Regional Oximetry for Pediatric Patients 200
      • 4.2.6.47 Masimo Announces the Full Market Release of Early Warning Score (EWS) with the Root® Patient Monitoring and Connectivity Hub 200
      • 4.2.6.48 Multicenter Study at UC Davis, UC Los Angeles, and Mayo Clinic Evaluates the Trend Accuracy of Masimo Continuous SpHb® 201
      • 4.2.6.49 Masimo Introduces Rad-G™ Pulse Oximeter 203
      • 4.2.6.50 Two Fire Rescue Departments Honored for Excellence in Emergency Medical Services 204
      • 4.2.6.51 Masimo Announces Full Market Release of Root® Patient Monitor and Connectivity Hub with Kite™ Supplemental Display System 206
      • 4.2.6.52 Massena Memorial Hospital of New York Adopts Masimo Root® and Masimo Patient SafetyNet™ 207
      • 4.2.6.53 Masimo Announces CE Marking of Rad-97™Pulse CO-Oximeter® and Connectivity Hub with Noninvasive Blood Pressure 209
      • 4.2.6.54 New Study Evaluates the Utility of Masimo SpHb® Monitoring During Liver Transplantation 210
      • 4.2.6.55 Masimo Announces Availability of the RD SedLine® Adult EEG Sensor 212
      • 4.2.6.56 Masimo Announces Recent Study Monitoring Methemoglobin Levels During Administration of Inhaled Nitric Oxide 213
      • 4.2.6.57 Masimo Announces CE Marking of Respiration Rate Measurement on MightySat™ Rx 214
      • 4.2.6.58 Masimo Announces the Addition of Early Warning Score to the Root® Patient Monitoring and Connectivity Platform 215
      • 4.2.6.59 Masimo Reaffirms Commitment to India with Launch of Advanced Monitoring Technologies Made for India 217
      • 4.2.6.60 Masimo Announces FDA 510(k) Clearance for TFA-1™ Single-Patient-Use Forehead Sensor 218
      • 4.2.6.61 Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings 219
      • 4.2.6.62 Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions 221
      • 4.2.6.63 Adam Mikkelson of Camber Capital Management Joins Masimo's Board of Directors 222
      • 4.2.6.64 Study Investigates the Impact of Masimo Continuous SpHb® and Pvi® on Anesthesia-related Mortality 223
      • 4.2.6.65 Masimo Announces CE Marking of Rad-97™ Pulse CO-Oximeter® 225
      • 4.2.6.66 Masimo Partners with Smile Train to Advance Safe Surgery 226
      • 4.2.6.67 Masimo Foundation Co-Founds United for Oxygen Alliance 228
      • 4.2.6.68 Study on Abdominal Surgical Patients Investigates Clinical Utility of Masimo Pvi® 229
      • 4.2.6.69 New Study Finds Continuous, Noninvasive Hemoglobin Monitoring Using Masimo SpHb® May Reduce Intraoperative Red Blood Cell Transfusion 230
      • 4.2.6.70 Masimo MightySat™ is Available at Apple.com and Select Apple Retail Stores in the US and Canada 231
      • 4.2.6.71 Masimo Announces Amendment to Nellcor Royalty Agreement 232
      • 4.2.6.72 Masimo Announces a Special Worldwide Program for Total Hemoglobin (SpHb®) Monitoring for Areas Affected by the Zika Virus 232
      • 4.2.6.73 Masimo Announces CE Marking for RAS-45 Sensor for rainbow Acoustic Monitoring® of Respiration Rate 233
      • 4.2.6.74 New Article Showcases an Effective Surveillance System for General Care Units Using Masimo Patient SafetyNet™ 234
      • 4.2.6.75 Masimo Announces CE Marking for Pediatric O3™ Regional Oximetry 236
      • 4.2.6.76 Masimo Reports Second Quarter 2016 Financial Results 237
      • 4.2.6.77 Leading Ohio Critical Access Hospital Adopts Masimo Root® with Radius-7®, Radical-7®, and Patient SafetyNet™ to Create Hospital-Wide Wireless Monitoring and Clinician Notification System 239
      • 4.2.6.78 New Study Evaluates Masimo PVI® as a Predictor of Fluid Responsiveness in Patients Undergoing Liver Transplantation 240
      • 4.2.6.79 New Study Assesses Utility of 1st Generation Masimo Pronto® Pulse CO-Oximeter® with SpHb® Spot Check Technology in Evaluating Pediatric Trauma Patients 241
      • 4.2.6.80 One of the World's Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo's SedLine® Brain Function Monitoring and O3™ Regional Oximetry 242
      • 4.2.6.81 Masimo Announces FDA 510(k) Clearance for Radius-7® with rainbow® Technology, Including Continuous SpHb® 243
      • 4.2.6.82 New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology 245
      • 4.2.6.83 Masimo Announces 510(k) Clearance for O3™ Regional Oximetry 246
      • 4.2.6.84 One of India's Premier Maternal Care Specialists, Motherhood Hospitals, Standardizes on Masimo SET® Technology 247
      • 4.2.6.85 Masimo Reports First Quarter 2016 Financial Results 247
      • 4.2.6.86 One of France's University Hospitals Adopts Masimo Radical-7®, Including SpHb®, PVI®, and SET® Pulse Oximetry 249
      • 4.2.6.87 New Clinical Study Reports Relationship Between Masimo's Oxygen Reserve Index (ORI™) and Arterial Partial Pressure of Oxygen During Surgery 250
      • 4.2.6.88 Masimo Supports Larry Ellison's Announcement of Indian Wells CEO Raymond Moore's Resignation 251
      • 4.2.6.89 New Study Reports on Accuracy of Masimo's Blue® Sensors at Saturations below 85% in Children with Cyanotic Congenital Heart Disease 251
      • 4.2.6.90 Masimo Introduces SafetyNet™ Surveillance at HIMSS16 252
      • 4.2.6.91 Masimo Announces Iris™ Gateway at HIMSS16 253
      • 4.2.6.92 Masimo Reports Fourth Quarter and Fiscal Year 2015 Financial Results 254
      • 4.2.6.93 Masimo Announces FDA 510(k) Clearance for Root® with Noninvasive Blood Pressure and Temperature 256
      • 4.2.6.94 Masimo's rainbow® Acoustic Monitoring (RAM™) was Associated with Fewer Alarm Events During Planned Moderate Sedation in New Clinical Study 258
      • 4.2.6.95 In New Clinical Study Masimo's Oxygen Reserve Index Helps Clinicians Detect Impending Desaturation in Pediatric Patients 259
      • 4.2.6.96 New Study Shows Utility of Masimo rainbow Acoustic Monitoring™ 260
      • 4.2.6.97 North Carolina's Appalachian Regional Healthcare System Selects Patient SafetyNet™ and Radius-7™ 261
      • 4.2.6.98 Masimo to Debut Respiration Rate in MightySat™ at Consumer Electronics Show - First Fingertip Pulse Oximeter to Measure Breath Rate 262
    • 4.2.7 Medtronic 264
      • 4.2.7.1 Medtronic Announces Paurvi Bhatt as President of Medtronic Foundation 264
      • 4.2.7.2 Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy 264
      • 4.2.7.3 Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 266
      • 4.2.7.4 Medtronic Launches New Telehealth Solutions in Support of U.S. Department of Veterans Affairs National Contract 270
      • 4.2.7.5 Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities 271
      • 4.2.7.6 Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation 272
      • 4.2.7.7 Medtronic Completes Sale of a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health 273
      • 4.2.7.8 Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 274
      • 4.2.7.9 Medtronic Study Finds High Use of App-Based Remote Cardiac Monitoring Among Older Patients 278
      • 4.2.7.10 New Study Shows Medtronic Insertable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients 280
      • 4.2.7.11 Medtronic Signs Definitive Agreement to Divest a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health for $6.1 Billion 282
      • 4.2.7.12 Medtronic Syncs Garmin® Activity Tracker Data Directly into Remote Patient Monitoring Mobile Platform 283
      • 4.2.7.13 New Guidelines Support Use of Cardiac Monitoring for Patients with Unexplained Fainting 284
      • 4.2.7.14 New Partnership Between Medtronic and Atlas General Hospital Brings Advanced Surgical Technologies and Treatment Options to Serbia 286
      • 4.2.7.15 Medtronic Receives FDA Clearance for Reveal LINQ? Insertable Cardiac Monitor (ICM) with TruRhythm? Detection 287
      • 4.2.7.16 Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 288
      • 4.2.7.17 Medtronic and Fitbit Partner to Integrate Health and Activity Data Into New CGM Solution for Simplified Type 2 Diabetes Management 289
      • 4.2.7.18 MiniMed® Connect Mobile Accessory for Android Now Available from Medtronic 291
      • 4.2.7.19 Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging 293
      • 4.2.7.20 Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 295
      • 4.2.7.21 Medtronic Announces Approval and Launch of Reveal LINQ? Insertable Cardiac Monitor in Japan 296
      • 4.2.7.22 Medtronic Reports First Quarter Financial Results 297
      • 4.2.7.23 Medtronic Announces Beacon Heart Failure Management Service, Furthering Its Commitment to Delivering Value in Healthcare 301
      • 4.2.7.24 Medtronic Outlines Future Growth Vision at Investor Day 302
      • 4.2.7.25 Medtronic Strengthens Commitment to Asia Pacific 303
      • 4.2.7.26 Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 305
      • 4.2.7.27 Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 309
      • 4.2.7.28 Medtronic Announces the Pricing Terms of Its Cash Tender Offer of Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A. 311
      • 4.2.7.29 Medtronic Announces the Early Results and Upsizing of Its Cash Tender Offer for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A. 313
      • 4.2.7.30 Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 315
      • 4.2.7.31 Medtronic Announces Cash Tender Offer for Up to $2.75 Billion Aggregate Purchase Price of Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A. 315
      • 4.2.7.32 Medtronic Proposes Proxy Access 318
      • 4.2.7.33 Medtronic Reports Third Quarter Financial Results 318
      • 4.2.7.34 Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2016 322
    • 4.2.8 Mindray Medical 322
      • 4.2.8.1 Mindray Showcased Star Products at Hospitalar 2018 322
      • 4.2.8.2 Mindray Showcased New Innovations at CMEF Spring 2018 324
      • 4.2.8.3 ECR 2018: Envision more with the insightful solution 326
      • 4.2.8.4 Mindray shined at Arab Health & MEDLAB Dubai 2018 327
      • 4.2.8.5 Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport 329
      • 4.2.8.6 Mindray Showcases Latest Innovation at MEDICA 2017 330
      • 4.2.8.7 Mindray becomes the first Chinese company to obtain List A CE mark 332
      • 4.2.8.8 Mindray Showcased Comprehensive Portfolio at Hospitalar 2017 333
      • 4.2.8.9 Mindray's Innovations Shined at the 77th CMEF 334
      • 4.2.8.10 Mindray Shined at ECR 2017 in Vienna 335
      • 4.2.8.11 Mindray showcased Latest Innovations at Arab Health 2017 336
      • 4.2.8.12 Mindray Showcases Latest Innovations at MEDICA 2016 338
      • 4.2.8.13 Notice of ruling in favor of Mindray Medical International Co., Ltd. In its action against Edan Instruments, Inc. on the infringement of intellectual property rights 339
      • 4.2.8.14 Mindray Release its New Hand-Carried M6 Ultrasound System 341
      • 4.2.8.15 New Waves in Ultrasound Innovation: Mindray Releases Its Premium Resona 6 Ultrasound System 341
      • 4.2.8.16 Mindray Releases New Generation DC-40 Ultrasound System 342
      • 4.2.8.17 Mindray Releases New Generation DC-30 Ultrasound System 343
      • 4.2.8.18 Mindray officially launched Resona 7 ultrasound system in Europe at ECR 2016 344
      • 4.2.8.19 Mindray BeneVision N22/N19 Patient Monitor Wins the iF DESIGN AWARD 2016 345
    • 4.2.9 Natus Medical 346
      • 4.2.9.1 Natus Medical Announces Second Quarter Financial Results 346
      • 4.2.9.2 Natus Medical Announces Leadership Changes 348
      • 4.2.9.3 Natus Confirms Receipt of Notice of Voce Capital's Intent to Nominate Director Candidates to Replace 50% of the Natus Board 350
      • 4.2.9.4 Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results 351
      • 4.2.9.5 Natus Medical Announces 2018 Annual and First Quarter Financial Guidance 354
      • 4.2.9.6 Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit 357
      • 4.2.9.7 Natus to be Exclusive U.S. Agent for the First Neonatal MRI Device 358
      • 4.2.9.8 Natus Completes Acquisition of Neurosurgery Assets from Integra LifeSciences 358
      • 4.2.9.9 Natus Medical Announces Fourth Quarter and Full Year 2016 Financial Results 358
      • 4.2.9.10 Natus Completes Acquisition of GN Otometrics Business 362
      • 4.2.9.11 Natus Medical Announces Appointment of Barbara R. Paul, M.D. to its Board of Directors 362
      • 4.2.9.12 Natus Medical Acquires RetCam Ophthalmic Imaging System 363
      • 4.2.9.13 Natus Medical Adds to Its Neurodiagnostic Service Market 363
      • 4.2.9.14 Natus Medical Announces Record Fourth Quarter and Full Year 2015 Financial Results 363
      • 4.2.9.15 Natus Medical Announces Preliminary Revenue For The First Quarter 2016 366
      • 4.2.9.16 Natus Medical Announces Record Fourth Quarter And Full Year 2015 Financial Results 366
      • 4.2.9.17 Natus Medical Announces 2016 Annual And First Quarter Financial Guidance 369
    • 4.2.10 Nihon Kohden 370
      • 4.2.10.1 NIHon Kohden Launches Award-Winning Augmented Reality App At HIMSS18 370
      • 4.2.10.2 Nihon Kohden Launches Aireeg® WEE-1200 Wireless EEG System At HIMSS18 371
      • 4.2.10.3 Nihon Kohden Launches NK-HIQ™ Wireless Patientmonitoring System At HIMSS18 372
      • 4.2.10.4 Nihon Kohden Introduces New Bedside Monitor Designed to Meet Precise Needs of Ambulatory Surgery, Specialty Centers 373
      • 4.2.10.5 Nihon Kohden Expands U.S. Operations with New Pennsylvania Facility 374
      • 4.2.10.6 Nihon Kohden Awarded New Equipment, Supplies Contract with Premier, Inc. 374
      • 4.2.10.7 Nihon Kohden Introduces Life Scope G9 Monitor, Designed to be Personalized to Individual Patient Need 375
      • 4.2.10.8 Nihon Kohden Debuts Breakthrough in Neuromonitoring Remote Access with Live View Panel 376
      • 4.2.10.9 Nihon Kohden Unveils New Alarm Management and Reporting Software System to Help Hospitals Address Alarm Fatigue 377
      • 4.2.10.10 Nihon Kohden establishes sales subsidiary in Mexico 378
    • 4.2.11 Nonin Medical 379
      • 4.2.11.1 Pulse Oximetry Saturation Values Differ Between Finger, Ear 379
      • 4.2.11.2 Oximetry You Can Trust: Even in the Most Extreme Environments 380
      • 4.2.11.3 Nonin Medical Launches Next Generation LifeSense® II and RespSense® II Capnographs 381

LIST OF CHARTS

  • Chart 1 1: Patient Monitoring Equipment Market by Segment, U.S., 2015 - 2025 3
  • Chart 1 2: Patient Monitoring Equipment Market Overview, U.S., 2018 & 2025 3
  • Chart 2 1: Blood Pressure Monitoring Market by Segment, U.S., 2015 - 2025 37
  • Chart 2 2: Blood Pressure Monitoring Market Breakdown, U.S., 2018 38
  • Chart 2 3: Blood Pressure Monitoring Market Breakdown, U.S., 2025 39
  • Chart 2 4: Total Personal Blood Pressure Monitoring Market by Segment, U.S., 2015 - 2025 41
  • Chart 2 5: Total Personal Blood Pressure Monitoring Market, U.S., 2015 - 2025 43
  • Chart 2 6: Digital Personal Blood Pressure Monitoring Market, U.S., 2015 - 2025 45
  • Chart 2 7: Aneroid Personal Blood Pressure Monitoring Market, U.S., 2015 - 2025 47
  • Chart 2 8: Total Professional Blood Pressure Monitoring Market by Segment, U.S., 2015 - 2025 49
  • Chart 2 9: Total Professional Blood Pressure Monitoring Market, U.S., 2015 - 2025 51
  • Chart 2 10: Digital Professional Blood Pressure Monitoring Market, U.S., 2015 - 2025 54
  • Chart 2 11: Aneroid Professional Blood Pressure Monitoring Market, U.S., 2015 - 2025 56
  • Chart 2 12: Leading Competitors, Blood Pressure Monitoring Market, U.S., 2018 64

LIST OF FIGURES

  • Figure 1 1: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (1 of 2) 4
  • Figure 1 2: Patient Monitoring Device Market Share Ranking by Segment, U.S., 2018 (2 of 2) 5
  • Figure 1 3: Companies Researched in this Report, U.S., 2018 (1 of 3) 6
  • Figure 1 4: Companies Researched in this Report, U.S., 2018 (2 of 3) 7
  • Figure 1 5: Companies Researched in this Report, U.S., 2018 (3 of 3) 8
  • Figure 1 6: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (1 of 2) 9
  • Figure 1 7: Factors Impacting the Patient Monitoring Equipment Market by Segment, U.S. (2 of 2) 10
  • Figure 1 8: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (1 of 3) 11
  • Figure 1 9: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (2 of 3) 12
  • Figure 1 10: Recent Events in the Patient Equipment Monitoring Market, U.S., 2015 - 2018 (3 of 3) 13
  • Figure 1 11: Patient Monitoring Equipment Markets Covered, U.S., 2018 (1 of 5) 14
  • Figure 1 12: Patient Monitoring Equipment Markets Covered, U.S., 2018 (2 of 5) 15
  • Figure 1 13: Patient Monitoring Equipment Markets Covered, U.S., 2018 (3 of 5) 16
  • Figure 1 14: Patient Monitoring Equipment Markets Covered, U.S., 2018 (4 of 5) 17
  • Figure 1 15: Patient Monitoring Equipment Markets Covered, U.S., 2018 (5 of 5) 18
  • Figure 1 16: Key Report Updates 19
  • Figure 1 17: Version History 19
  • Figure 2 1: Blood Pressure Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 36
  • Figure 2 2: Total Personal Blood Pressure Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 40
  • Figure 2 3: Total Personal Blood Pressure Monitoring Market, U.S., 2015 - 2025 42
  • Figure 2 4: Digital Personal Blood Pressure Monitoring Market, U.S., 2015 - 2025 44
  • Figure 2 5: Aneroid Personal Blood Pressure Monitoring Market, U.S., 2015 - 2025 46
  • Figure 2 6: Total Professional Blood Pressure Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 48
  • Figure 2 7: Total Professional Blood Pressure Monitoring Market, U.S., 2015 - 2025 50
  • Figure 2 8: Digital Professional Blood Pressure Monitoring Market, U.S., 2015 - 2025 53
  • Figure 2 9: Aneroid Professional Blood Pressure Monitoring Market, U.S., 2015 - 2025 55
  • Figure 2 10: Drivers and Limiters, Blood Pressure Monitoring Market, U.S., 2018 59
  • Figure 2 11: Leading Competitors, Blood Pressure Monitoring Market, U.S., 2018 63
  • Figure 4 1: Press Release Summary 68
Back to Top